Prognostic Factor Analysis and Nomogram Development in Castration-Resistant Prostate Cancer with Visceral Metastases for Future Radionuclide Therapy Selection.

Xu P, Lin X, Zhu Y, Chen J, Yang B.

Open source

DOI
10.1177/10849785261460356
Published
2026-07-29
Container
Cancer Biother Radiopharm
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/10849785261460356,
  title = {Prognostic Factor Analysis and Nomogram Development in Castration-Resistant Prostate Cancer with Visceral Metastases for Future Radionuclide Therapy Selection.},
  author = {Xu P and  Lin X and  Zhu Y and  Chen J and  Yang B.},
  year = {2026},
  journal = {Cancer Biother Radiopharm},
  doi = {10.1177/10849785261460356},
  url = {https://doi.org/10.1177/10849785261460356}
}

RIS

TY  - JOUR
TI  - Prognostic Factor Analysis and Nomogram Development in Castration-Resistant Prostate Cancer with Visceral Metastases for Future Radionuclide Therapy Selection.
AU  - Xu P
AU  -  Lin X
AU  -  Zhu Y
AU  -  Chen J
AU  -  Yang B.
PY  - 2026
JO  - Cancer Biother Radiopharm
DO  - 10.1177/10849785261460356
UR  - https://doi.org/10.1177/10849785261460356
ER  - 

APA

P, X., X, L., Y, Z., J, C., & B., Y. (2026). Prognostic Factor Analysis and Nomogram Development in Castration-Resistant Prostate Cancer with Visceral Metastases for Future Radionuclide Therapy Selection.. Cancer Biother Radiopharm. https://doi.org/10.1177/10849785261460356

Source records